Consensus statementInterpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
Under an Elsevier user license
open archive
Key words
Chronic pain
randomized clinical trials
outcome measures
clinical importance
assessment
quality of life
physical functioning
emotional functioning
global ratings
Cited by (0)
Supported by unrestricted grants to the University of Rochester Office of Professional Education from Allergan, Alpharma, AstraZeneca, Celgene, Elan, Endo, GlaxoSmithKline, Johnson & Johnson, Merck, NeurogesX, Pfizer, Purdue, and Schwarz Biosciences.
The views expressed in this article are those of the authors. No official endorsement by the US Department of Veterans Affairs, US Food and Drug Administration, US National Institutes of Health, or the pharmaceutical companies that provided unrestricted grants to the University of Rochester Office of Professional Education should be inferred.
Copyright © 2008 American Pain Society. Published by Elsevier Inc. All rights reserved.